| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |